Looking ahead, with the advancement of research technologies, the S100A8/A9 protein is expected to become a new focus for the diagnosis and treatment of cardiovascular diseases, potentially revolutionizing clinical approaches to diagnosis and therapy. Here, IGKV1D-22 is linked to cardiovascular disorder.